1. Home
  2. CDNA vs HQH Comparison

CDNA vs HQH Comparison

Compare CDNA & HQH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareDx Inc.

CDNA

CareDx Inc.

N/A

Current Price

$22.36

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Logo abrdn Healthcare Investors Shares of Beneficial Interest

HQH

abrdn Healthcare Investors Shares of Beneficial Interest

HOLD

Current Price

$18.94

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDNA
HQH
Founded
1998
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Finance Companies
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.1B
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
CDNA
HQH
Price
$22.36
$18.94
Analyst Decision
Buy
Analyst Count
6
0
Target Price
$28.00
N/A
AVG Volume (30 Days)
582.4K
142.3K
Earning Date
04-28-2026
01-01-0001
Dividend Yield
N/A
11.56%
EPS Growth
N/A
N/A
EPS
0.05
1.09
Revenue
$48,324,000.00
N/A
Revenue This Year
$16.01
N/A
Revenue Next Year
$11.31
N/A
P/E Ratio
$446.20
$17.42
Revenue Growth
18.93
N/A
52 Week Low
$10.96
$15.09
52 Week High
$23.24
$20.46

Technical Indicators

Market Signals
Indicator
CDNA
HQH
Relative Strength Index (RSI) 63.84 41.97
Support Level $15.80 $19.07
Resistance Level N/A $19.57
Average True Range (ATR) 0.94 0.36
MACD 0.06 -0.11
Stochastic Oscillator 93.76 16.03

Price Performance

Historical Comparison
CDNA
HQH

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

About HQH abrdn Healthcare Investors Shares of Beneficial Interest

abrdn Healthcare Investors Formerly Tekla Healthcare Investors is the United States based non-diversified closed-end management investment company. Its objective is to seek long-term capital appreciation by investing in securities of healthcare companies. In addition, the fund seeks to provide regular distribution of realized capital gains. The fund invests in the securities of public and private companies.

Share on Social Networks: